Top

CardioVascular and Interventional Radiology

Published in:

01-04-2015 | Laboratory Investigation

Sphere-Enhanced Microwave Ablation (sMWA) Versus Bland Microwave Ablation (bMWA): Technical Parameters, Specific CT 3D Rendering and Histopathology

Authors: T. L. Gockner, S. Zelzer, T. Mokry, D. Gnutzmann, N. Bellemann, C. Mogler, A. Beierfuß, E. Köllensperger, G. Germann, B. A. Radeleff, U. Stampfl, H. U. Kauczor, P. L. Pereira, C. M. Sommer

Published in: CardioVascular and Interventional Radiology | Issue 2/2015

Abstract

Purpose

This study was designed to compare technical parameters during ablation as well as CT 3D rendering and histopathology of the ablation zone between sphere-enhanced microwave ablation (sMWA) and bland microwave ablation (bMWA).

Methods

In six sheep-livers, 18 microwave ablations were performed with identical system presets (power output: 80 W, ablation time: 120 s). In three sheep, transarterial embolisation (TAE) was performed immediately before microwave ablation using spheres (diameter: 40 ± 10 μm) (sMWA). In the other three sheep, microwave ablation was performed without spheres embolisation (bMWA). Contrast-enhanced CT, sacrifice, and liver harvest followed immediately after microwave ablation. Study goals included technical parameters during ablation (resulting power output, ablation time), geometry of the ablation zone applying specific CT 3D rendering with a software prototype (short axis of the ablation zone, volume of the largest aligned ablation sphere within the ablation zone), and histopathology (hematoxylin-eosin, Masson Goldner and TUNEL).

Results

Resulting power output/ablation times were 78.7 ± 1.0 W/120 ± 0.0 s for bMWA and 78.4 ± 1.0 W/120 ± 0.0 s for sMWA (n.s., respectively). Short axis/volume were 23.7 ± 3.7 mm/7.0 ± 2.4 cm³ for bMWA and 29.1 ± 3.4 mm/11.5 ± 3.9 cm³ for sMWA (P < 0.01, respectively). Histopathology confirmed the signs of coagulation necrosis as well as early and irreversible cell death for bMWA and sMWA. For sMWA, spheres were detected within, at the rim, and outside of the ablation zone without conspicuous features.

Conclusions

Specific CT 3D rendering identifies a larger ablation zone for sMWA compared with bMWA. The histopathological signs and the detectable amount of cell death are comparable for both groups. When comparing sMWA with bMWA, TAE has no effect on the technical parameters during ablation.

Gillams A (2009) Tumour ablation: current role in the kidney, lung and bone. Cancer Imaging 9 Spec No A:S68-70

Pompili M, Saviano A, de Matthaeis N et al (2013) Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol 59(1):89–97CrossRefPubMed

Rutherford EE, Cast JE, Breen DJ (2008) Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol 63(2):220–230CrossRefPubMed

Brace CL (2009) Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 38(2):61–67CrossRefPubMedCentralPubMed

Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation: principles and applications. Radiographics 25(Suppl 1):S69–S83CrossRefPubMed

Sommer CM, Lemm G, Hohenstein E et al (2013) CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results. Cardiovasc Intervent Radiol 36(3):731–737CrossRefPubMed

Andreano A, Huang Y, Meloni MF, Lee FT Jr, Brace C (2010) Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys 37(6):2967–2973CrossRefPubMedCentralPubMed

Ni JY, Liu SS, Xu LF, Sun HL, Chen YT (2013) Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 19(24):3872–3882CrossRefPubMedCentralPubMed

Xu LF, Sun HL, Chen YT et al (2013) Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol 28(3):456–463CrossRefPubMed

10.

Vollherbst D, Fritz S, Zelzer S et al (2014) Specific CT 3D rendering of the treatment zone after irreversible electroporation (IRE) in a pig liver model: the “Chebyshev Center Concept” to define the maximum treatable tumor size. BMC Med Imaging 14:2CrossRefPubMedCentralPubMed

11.

Sommer CM, Koch V, Pap B et al (2011) Effect of tissue perfusion on microwave ablation: experimental in vivo study in porcine kidneys. J Vasc Interv Radiol 22(12):1751–1757CrossRefPubMed

12.

Sommer CM, Kortes N, Zelzer S et al (2011) Renal artery embolization combined with radiofrequency ablation in a porcine kidney model: effect of small and narrowly calibrated microparticles as embolization material on coagulation diameter, volume, and shape. Cardiovasc Intervent Radiol 34(1):156–165CrossRefPubMed

13.

Hoffmann R, Rempp H, Clasen S (2012) Microwave tumor ablation. new devices, new applications? Radiologe 52(1):22–28CrossRefPubMed

14.

Sommer CM, Arnegger F, Koch V et al (2012) Microwave ablation of porcine kidneys in vivo: effect of two different ablation modes (“temperature control” and “power control”) on procedural outcome. Cardiovasc Intervent Radiol 35(3):653–660CrossRefPubMed

15.

Zhang YJ, Liang HH, Chen MS et al (2007) Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 244(2):599–607CrossRefPubMed

16.

Wang X, Sofocleous CT, Erinjeri JP et al (2013) Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol 36(1):166–175CrossRefPubMedCentralPubMed

17.

Sommer CM, Sommer SA, Sommer WO et al (2013) Optimisation of the coagulation zone for thermal ablation procedures: a theoretical approach with considerations for practical use. Int J Hyperthermia 29(7):620–628CrossRefPubMed

18.

Stampfl S, Bellemann N, Stampfl U et al (2009) Arterial distribution characteristics of Embozene particles and comparison with other spherical embolic agents in the porcine acute embolization model. J Vasc Interv Radiol 20(12):1597–1607CrossRefPubMed

19.

Iwamoto T, Kawai N, Sato M et al (2008) Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure. J Vasc Interv Radiol 19(11):1646–1651CrossRefPubMed

Title: Sphere-Enhanced Microwave Ablation (sMWA) Versus Bland Microwave Ablation (bMWA): Technical Parameters, Specific CT 3D Rendering and Histopathology
Authors: T. L. Gockner
S. Zelzer
T. Mokry
D. Gnutzmann
N. Bellemann
C. Mogler
A. Beierfuß
E. Köllensperger
G. Germann
B. A. Radeleff
U. Stampfl
H. U. Kauczor
P. L. Pereira
C. M. Sommer
Publication date: 01-04-2015
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 2/2015
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-014-0964-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sphere-Enhanced Microwave Ablation (sMWA) Versus Bland Microwave Ablation (bMWA): Technical Parameters, Specific CT 3D Rendering and Histopathology

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2015

Spleen: Promised Land for New and Novel Interventions?

Acute Stroke and Obstruction of the Extracranial Carotid Artery Combined with Intracranial Tandem Occlusion: Results of Interventional Revascularization

Endovascular Repair of a Complex Splenic Artery Aneurysm Using a Multilayer Stent

An Ice Block: A Novel Technique of Successful Prevention of Cement Leakage Using an Ice Ball

Temporary Arterial Embolization of Liver Parenchyma with Degradable Starch Microspheres (EmboCept®S) in a Swine Model

Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma